Lindegaard J C
Department of Experimental Clinical Oncology, Radiumstationen, Aarhus, Denmark.
Int J Hyperthermia. 1992 Sep-Oct;8(5):561-86. doi: 10.3109/02656739209037994.
A few minute's exposure to a high temperature (sensitizing treatment, ST) may substantially increase the cytotoxic and the radiosensitizing effect of a subsequent heating at a lower temperature (test treatment, TT). This phenomenon, which is known as step-down heating (SDH) or thermosensitization, has been observed both in cultured cells in vitro and in tumours and normal tissues in vivo. The effect of SDH increases with a lowering of TT temperature, but it is rapidly lost at temperatures very close to 37 degrees C. SDH-induced thermosensitization decays within a few hours, when an interval is inserted between ST and TT. In vitro results suggest an exponential decay of the SDH effect with half times ranging from 1.5- to 3.1 h. The effect of SDH increases with increasing ST time or temperature. For single heating, the Arrhenius plot is biphasic with activation energies of 500-800 and 1200-1700 kJ/mol above and below a break point temperature in the region 42.5-43.0 degrees C, respectively. For SDH, the Arrhenius plot gradually becomes monophasic with increasing severity of ST and it approaches asymptotically to an activation energy of about 400 kJ/mol. The reduction of the activation energy depends on cell survival after the priming ST and not on the specific ST heating time or temperature. SDH strongly enhances hyperthermic radiosensitization with a 5-6-fold reduction of the radiation dose required to achieve tumour control. The thermosensitizing and the radiosensitizing effects of SDH have several features in common. Both effects become more prominent when the TT temperature is decreased and when the ST heating time or temperature increases. In addition, the decay kinetics for both effects are comparable. For heat alone, the effect of SDH in tumour and normal tissue seems to be quantitatively similar. However, the therapeutic ratio may be increased by combining SDH with radiation. Biologically, the critical subcellular targets involved in the SDH effect have not been revealed. However, the ability of SDH to inhibit the clearance of heat-induced aggregation of proteins in the nucleus is interesting. Blockage of the nuclear function by proteins is a central theory in the present molecular biological models for both cell kill by heat and heat radiosensitization. Clinically, SDH may be an advantage since even a short exposure to high temperature increases the effect of an otherwise inadequate heat treatment. The disadvantages are that SDH complicates thermal dose calculations, and may cause unacceptable damage to normal tissue.
暴露于高温几分钟(致敏处理,ST)可显著增强随后在较低温度下加热(测试处理,TT)的细胞毒性和放射增敏作用。这种现象,即所谓的逐步降温加热(SDH)或热致敏,已在体外培养细胞以及体内肿瘤和正常组织中观察到。SDH的效果随着TT温度的降低而增强,但在非常接近37℃的温度下会迅速消失。当在ST和TT之间插入一个间隔时,SDH诱导的热致敏在数小时内衰减。体外结果表明SDH效应呈指数衰减,半衰期在1.5至3.1小时之间。SDH的效果随着ST时间或温度的增加而增强。对于单次加热,阿累尼乌斯曲线呈双相,在42.5 - 43.0℃区域的断点温度以上和以下,活化能分别为500 - 800和1200 - 1700 kJ/mol。对于SDH,随着ST强度的增加,阿累尼乌斯曲线逐渐变为单相,并渐近于约400 kJ/mol的活化能。活化能的降低取决于引发ST后的细胞存活情况,而不是特定的ST加热时间或温度。SDH强烈增强热放射增敏作用,使实现肿瘤控制所需的辐射剂量降低5 - 6倍。SDH的热致敏和放射增敏作用有几个共同特征。当TT温度降低以及ST加热时间或温度增加时,这两种作用都变得更加显著。此外,这两种作用的衰减动力学具有可比性。对于单独加热,SDH在肿瘤和正常组织中的效果在数量上似乎相似。然而,将SDH与放射相结合可能会提高治疗比率。从生物学角度来看,尚未揭示参与SDH效应的关键亚细胞靶点。然而,SDH抑制热诱导的细胞核内蛋白质聚集清除的能力很有趣。蛋白质对核功能的阻断是当前关于热致细胞死亡和热放射增敏的分子生物学模型的核心理论。在临床上,SDH可能具有优势,因为即使短时间暴露于高温也会增强原本不足够的热处理效果。缺点是SDH使热剂量计算复杂化,并且可能对正常组织造成不可接受的损伤。